This episode delves into the surprising historical connection between psychedelics and Silicon Valley's early tech scene, revealing how substances like LSD reportedly influenced the design of computer chips and foundational internet technologies. It explores the broader medical and social implications of psychedelics, discussing their potential role in treating mental health conditions and the path toward greater social acceptance and legalization.
Key takeaways
Understand the historical link between early Silicon Valley tech innovation (Ampex, Doug Engelbart) and psychedelic experimentation, particularly LSD, in the 1950s.
Recognize the evolving medical perspective on psychedelics, focusing on their therapeutic potential for conditions like depression, anxiety, and addiction.
Consider the societal shifts and ongoing research that could lead to the legalization and broader social acceptance of psychedelics for therapeutic uses.
Explore Michael Pollan's research methodology in understanding the historical and cultural prevalence of mind-altering substances across human societies.
Journalist and author Michael Pollan talks with Recode’s Kara Swisher about his new book, “How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence.” Pollan, perhaps best known for his books about food, like “The Omnivore’s Dilemma,” says the new book traces his learning process as he tried to understand why almost every human society has experimented with mind-altering substances. Silicon Valley is certainly no exception: Pollan says that tech pioneer Ampex was ground zero of the tech scene’s experimentation with LSD, starting in the 1950s; engineers discovered that dropping acid helped them design the first computer chips, and shared this finding with Doug Engelbart, who would go to invent the mouse, the graphical user interface and key components of the internet. Pollan also talks about the broader medical, political and social implications of using psychedelics, and how they might one day become legal and more socially acceptable in America.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Understand the historical link between early Silicon Valley tech innovation (Ampex, Doug Engelbart) and psychedelic experimentation, particularly LSD, in the 1950s.
What's takeaway #2 from this episode?
Recognize the evolving medical perspective on psychedelics, focusing on their therapeutic potential for conditions like depression, anxiety, and addiction.
What's takeaway #3 from this episode?
Consider the societal shifts and ongoing research that could lead to the legalization and broader social acceptance of psychedelics for therapeutic uses.
What's takeaway #4 from this episode?
Explore Michael Pollan's research methodology in understanding the historical and cultural prevalence of mind-altering substances across human societies.
